Memorias do Instituto Oswaldo Cruz

Papers
(The TQCC of Memorias do Instituto Oswaldo Cruz is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease30
Do the new triatomine species pose new challenges or strategies for monitoring Chagas disease? An overview from 1979-202127
The translational challenge in Chagas disease drug development23
Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy22
Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells22
Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission20
Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory17
The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field14
Emerging and reemerging forms of Trypanosoma cruzi transmission14
Family Herpesviridae and neuroinfections: current status and research in progress14
Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi12
Prognosis of chronic Chagas heart disease and other pending clinical challenges12
Systematic review on the biology, ecology, genetic diversity and parasite transmission potential of Panstrongylus geniculatus (Latreille 1811) in Latin America12
Why do we still have not a vaccine against Chagas disease?12
Perspectives for a new drug candidate for Chagas disease therapy11
Chagas disease in the context of the 2030 agenda: global warming and vectors11
Urban infestation by Triatoma infestans (Hemiptera: Reduviidae), an overlooked phenomena for Chagas disease in Argentina11
Genomics and functional genomics in Leishmania and Trypanosoma cruzi: statuses, challenges and perspectives10
Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis10
Fast surveillance response reveals the introduction of a new yellow fever virus sub-lineage in 2021, in Minas Gerais, Brazil10
Computational approaches towards the discovery and optimisation of cruzain inhibitors9
Evaluation of LAMP for the diagnosis of Loa loa infection in dried blood spots compared to PCR-based assays and microscopy9
Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target9
Comparison of viral load between saliva and nasopharyngeal swabs for SARS-CoV2: the role of days of symptoms onset on diagnosis9
A short history of innate immunity9
Population movements, borders, and Chagas disease9
Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection8
Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening7
Is the mitochondrion a promising drug target in trypanosomatids?7
Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*7
Mycolicibacterium fortuitum genomic epidemiology, resistome and virulome7
Mechanism of action of glycyrrhizin against Plasmodium falciparum6
An emerging paradigm for the origin and evolution of shelled amoebae, integrating advances from molecular phylogenetics, morphology and paleontology6
Gene expression of Paracoccidioides virulence factors after interaction with macrophages and fibroblasts6
A history of over 40 years of potentially pathogenic free-living amoeba studies in Brazil - a systematic review6
Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations6
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease6
Flight tone characterisation of the South American malaria vector Anopheles darlingi (Diptera: Culicidae)6
Transmission cluster of COVID-19 cases from Uruguay: emergence and spreading of a novel SARS-CoV-2 ORF6 deletion5
Detection of non-tuberculosus mycobacteria (NTMs) in lung samples using 16S rRNA5
Evaluation of cytochrome b sequence to identify Leishmania species and variants: the case of Panama5
Chagas disease affects the human placental barrier’s turnover dynamics during pregnancy5
Sand fly behavior: much more than weak-flying5
Differential expression profiles of miRNAs and their putative targets in Schistosoma mansoni during its life cycle5
Critical analysis of Chagas disease treatment in different countries5
Multidisciplinary approach detects speciation within the kissing bug Panstrongylus rufotuberculatus populations (Hemiptera, Heteroptera, Reduviidae)5
Article-processing charges as a barrier for science in low-to-medium income regions5
First report of Leishmania RNA virus 1 in Leishmania (Viannia) braziliensis clinical isolates from Rio de Janeiro State - Brazil5
Epidemiology of paracoccidioidomycosis in Venezuela: a retrospective study from 1954 to 20195
Antigenicity and adhesiveness of a Plasmodium vivax VIR-E protein from Brazilian isolates5
How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day5
First report of putative Leishmania RNA virus 2 (LRV2) in Leishmania infantum strains from canine and human visceral leishmaniasis cases in the southeast of Brazil5
Giardiasis in urban and rural Amazonas, Brazil is driven by zoonotic and cosmopolitan A and B assemblages4
Molecular aspects of Chikungunya virus infections in cancer patients4
Should COVID-19 be branded to viral thrombotic fever?4
Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved*4
Cerebrospinal fluid: a target of some fungi and an overview4
Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon4
Enterovirus infection and its relationship with neurodegenerative diseases4
Molecular epidemiology of Mycobacterium tuberculosis in Brazil before the whole genome sequencing era: a literature review4
SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil4
Inhibition of nitric oxide production of activated mice peritoneal macrophages is independent of the Toxoplasma gondii strain4
The adaptation of SARS-CoV-2 to humans4
Chagas disease treatment: a 120-year-old challenge to public health4
Toxoplasma gondii in the faeces of wild felids from the Atlantic Forest, Brazil4
0.028668880462646